Nest Pharma Private Limited, a active private limited company, was established on 19 March 2009 in Amberpet, Telangana, India. Engaging in api manufacturers within the trade sector, it holds CIN: U24233TG2009PTC063111. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.25 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Madhukar Reddy Gujjula (Managing Director), Vijender Reddy Kalluri (Director), Raghu J Reddy (Director). Past directors included Pallavi Nookala, Mandadi Abhirath Reddy, Ramakrishna Madireddy. It holds ₹4.80 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 133, First Floor, Mig-133, Shivam Road, Bathukammakunta, Amberpet, Telangana, 500013.
U24233TG2009PTC063111
063111
19 March 2009
₹1.00 Cr
₹5.25 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Nest Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhukar Reddy Gujjula | Managing Director | 19 Mar 2009 | Current |
| Vijender Reddy Kalluri | Director | 27 Mar 2022 | Current |
| Raghu J Reddy | Director | 05 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Mar 2022 | Past |
| Pramod Abcsdd | Director | 05 Apr 2024 | Past |
| Pramod Abcsdd | Director | 12 May 2011 | Past |
| Pramod Abcsdd | Director | 27 Jun 2012 | Past |
| Pramod Abcsdd | Director | 12 Oct 2009 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nest Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.98% increase. The company also saw a substantial improvement in profitability, with a 71.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Nest Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2014 | Bank Of India | ₹4.80 M | Open |
Explore comprehensive loan charge details -
Nest Pharma has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Raghu J Reddy was appointed as a Director was appointed as a Director on 05 Apr 2024 & has been associated with this company since 1 year 7 months . was completed.
Progress on Nest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Vijender Reddy Kalluri was appointed as a Director was appointed as a Director on 27 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
The activity A charge with Bank Of India of Rs. 0.48 Cr registered on 24 Apr 2014 with Charge ID 10490953 was modified on 13 Jan 2016. was completed.
A charge with Bank Of India amounted to Rs. 0.48 Cr with Charge ID 10490953 was registered on 24 Apr 2014. was recorded as a recent event.
The CIN of Nest Pharma Private Limited is U24233TG2009PTC063111.
Nest Pharma Private Limited is headquartered at Plot No. 133, First Floor, Mig-133, Shivam Road, Bathukammakunta, Amberpet, Telangana, 500013.
Nest Pharma Private Limited was incorporated on 19 March 2009.
The current directors of Nest Pharma Private Limited are
The primary industry of Nest Pharma Private Limited is Trade.
Nest Pharma Private Limited is unlisted.
The authorized capital of Nest Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.25 M.
The compliance status of Nest Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX